Technologies in diabetes

1. 1. Real-world Data Reveal Unmet Clinical Needs in Insulin Treatment in Asian People With Type 2 Diabetes: The Joint Asia Diabetes Evaluation (JADE) Register. Kong A. P. S, Lew T, Lau E. S. H, Lim L. L, Kesavadev J, Jia W, Sheu W. H-H, Sobrepena L, Tan A. T. B, Nguyen T. K, Yoon K, Wang K, Kodiappan K, Treuer T, Chan J. C. N, JADE Collaborative Study Group. Diabetes ObesMetab. 2020 Apr;22(4):669-679. Link 1 | Link 2
2. 2. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review. Kesavadev J, Srinivasan S, Saboo B, Krishna M. B, Krishnan G. Diabetes Ther. 2020. Link 1 | Link 2
3. 3. Exploratory CSII Randomized Controlled Trial on Erectile Dysfunction in T2DM Patients (ECSIITED). Kesavadev J, Pillai P. B. S, Shankar A, Warrier R. S, Ramachandran L, Jothydev S, Krishnan G. J Diabetes Sci Technol. 2018. 12(6). 1252-1253. Read More
4. 4. Cross-sectional Survey of Biosimilar Insulin Utilization in Asia: The Joint Asia Diabetes Evaluation Program. Gani L, Lau E, Luk A, Sobrepena L, Tran Q. K, Kesavadev J, Jia W, Yu W, Tsang C. C, Mukhopadhyay M, Jha S, Sheu W, Ho Y. K, Nguyen T. k, Ozaki R, So W. Y, Kwan C, Fu A. W. C, Mirasol R, Phatak S. R, Prasanna Kumar K. M, Sosale A, Janakiraman H, Chan J. C. N, JADE Collaborative Study Group.J Diabetes Investig. 2018 Nov; 9(6):1312-1322. Link 1 | Link 2
5. 5. CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective. Kesavadev J, Shankar A, Pillai P. B. S, Saboo B, Joshi S, Krishnan G, Jothydev S. Curr Diabetes Rev. 2016. 12(4). 312-314. Read More
6. 6. Fasting in Ramadan with an insulin pump. Kesavadev J. J Pak Med Assoc. 2015. 65(5S1). S47-50. Read More
7. 7. Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences. Kesavadev J, Das A.K, Unnikrishnan R, Joshi S. R, Ramachandran A, Shamsudeen J, Krishnan G, Jothydev S, Mohan V. Diabetes TechnolTher. 2010. 12(10). 823-831. Read More
8. 8. Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes. Kesavadev J, Balakrishnan S, Ahammed S, Jothydev S. Diabetes TechnolTher. 2009. 11(8). 517-521. Read More
9. 9. Assessing the Benefits of a Painless Lancing Device in a Subset of Patients Fearful of Finger Pricking. Warrier R, Badarudeen S, Shankar A, Krishnan G, Ramachandran L, Thampiraj K, Jothydev S, Kesavadev J. Diabetes TechnolTher. 2019. 21. A60-A61. Read More
10. 10. Patient and caregiver feedback on the first generation Artificial Pancreas in India. Kesavadev J, Ramachandran L, Shankar A, David A, Jose R, Anilkumar A L, Krishnan G, Jothydev S. Diabetes TechnolTher. 2018. 20(S1). A55-A56. Read More
11. 11. Better Outcomes in Type 2 Diabetes Management with a User Friendly Flash Glucose Monitoring System: Freestyle Libre Pro. Kesavadev J, Krishnan G, Saboo B, Shankar A, Ashok AD, Sanal G, Ramachandran L, Jothydev S. Diabetes TechnolTher. 2017. 19(S1).A1-A133. Read More
12. 12. Sharing the Outcomes and User Experience from India in The First 750 Type 2 Diabetes Patients with the New Libre Pro 14-Day Glucose Sensor. Kesavadev J, Ramachandran L, Shankar A, David A, Krishnan G, Srinivas S, Ajai A, Sanal G, Jothydev S. Diabetes. 2017. 66(S1). LB27-LB28. Read More
13. 13. Glucose monitoring technologies- Complementary or competitive? Role of Continuous Glucose Monitoring versus flash glucose monitoring versus self-monitoring of blood glucose. Kesavadev J, Ramachandran L, Krishnan G. J Diabetol. 2017. 8(3). 61-67. Review. Read More
14. 14. Comparing iPro2 with Libre for Sensor Accuracy and User Friendliness. Kesavadev J, Shankar A, Sanal G, Krishnan G, Jothydev S, Pillai P. B. Diabetes TechnolTher. 2016. 18(S1). A74. Read More
15. 15. Comparison of the New Factory Calibrated Sensor with Existing CGM Sensor. Kesavadev J, Pillai P. B. S, Shankar A, Ashok A.D, Sanal G, Iyer R, Krishnan G, Jothydev S. Diabetes. 2016. 65(S1). A230.P896. Read More
16. 16. Insulin pump therapy in pregnancy. Kesavadev J. J Pak Med Assoc. 2016. 66(9S1). S39-44.Review. Read More
17. 17. Impact of Insulin Pump Therapy on Erectile Dysfunction in Type 2 Diabetes. Kesavadev J, Pillai P. S, Shankar A, Jothydev S. Diabetes TechnolTher. 2015. 17. A40. Read More
18. 18. Use of Insulin Pumps in T2DM in India: Merits and Demerits learnt over a decade. Kesavadev J. O-86. Diabetes TechnolTher. 2014 Feb. 16(S1): A-1-A-162. Read More
19. 19. Use of Ipro2 in Real-Life Management of Type 2 Diabetes Patients In India. Mohan V, Kesavadev J, Jain S. M, Chawla M, Mutha A, Saboo B, Kovil R, Viswanathan V, Mithal A Punatar D, Shaikh, S, Shin J. P-311. Diabetes TechnolTher. 2014. 16(S1): A-1-A-162. Read More
20. 20. Attitudes and Behaviour Of Type 2 Diabetes Patients on Insulin Pumps. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Diabetes TechnolTher. 2013. 15(S1). A43- A44. Link 1 | Link 2
21. 21. Continuous insulin infusion systems in type 2 diabetes. Kesavadev J. J Assoc Physicians India. 2011 Apr. 59(S). 41-43. Read More
22. 22. Experiences with Insulin Pump in 52 Patients with Type 2 Diabetes in India. Kesavadev J, Kumar A, Ahammed S, JothydevS.Diabetes. 2008. 57(S1). 2021-PO. Read More
23. 23. Insulin Aspart Induced Lipoatrophy in a Patient on Insulin Pump. Kesavadev J, Kumar A, Ahammed S, Dinkar G, Jothydev S. Diabetes. 2008. 57(S1). 2093-PO. Read More
24. 24. Dramatic Response of Painful Peripheral Neuropathy with Insulin Pump in Type2 Diabetes. Kesavadev J, Rasheed S. A. Diabetes. 2007. 56 (S1). 2097-PO. Read More